Sirolimus reduces post-transplant skin cancer risk
08:58 EDT 7 Aug 2012 | Advanstar News Headlines
Patients who have undergone kidney transplants are less likely to develop skin cancer when given sirolimus for immunosuppression than if they receive calcineurin inhibitors, a French study suggests.
Original Article: Sirolimus reduces post-transplant skin cancer risk
More From BioPortfolio on "Sirolimus reduces post-transplant skin cancer risk"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
